These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12094649)

  • 1. [Otoacoustic emissions and auditory brain stem responses in insulin dependent diabetic patients].
    Lisowska G; Namysłowski G; Morawski K; Strojek K
    Otolaryngol Pol; 2002; 56(2):217-25. PubMed ID: 12094649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early identification of hearing impairment in patients with type 1 diabetes mellitus.
    Lisowska G; Namysłowski G; Morawski K; Strojek K
    Otol Neurotol; 2001 May; 22(3):316-20. PubMed ID: 11347633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early evaluation of auditory dysfunction in patients with type 2 diabetes mellitus].
    Aladağ I; Kurt S; Eyibilen A; Güven M; Erkorkmaz U
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):203-10. PubMed ID: 19052486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochlear dysfunction and diabetic microangiopathy.
    Lisowska G; Namysłowski G; Morawski K; Strojek K
    Scand Audiol Suppl; 2001; (52):199-203. PubMed ID: 11318468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting auditory brainstem evoked responses and distortion product otoacoustic emissions in diabetic patients with normal hearing.
    Cho WK; Kang WS; Lee JB; Park HJ; Chung JW; Ahn JH
    Auris Nasus Larynx; 2021 Apr; 48(2):227-234. PubMed ID: 32921527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of auditory evoked potentials and otoacoustic emissions in early detection of hearing abnormalities in Behçet's disease patients. A case control study.
    Nada DW; El Khouly RM; Gadow SE; Hablas SA; Aboelhawa MA; Al Ashkar DS; El Barbary AM; Hussein MS; Rageh E; Elsalawy AM; Abo-Zaid MH; Elshweikh S; El Gharib AM
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):45-52. PubMed ID: 29745880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiological examinations (ABR and DPOAE) of hearing organ in hemodialysed patients suffering from chronic renal failure].
    Gierek T; Markowski J; Kokot F; Paluch J; Wiecek A; Klimek D
    Otolaryngol Pol; 2002; 56(2):189-94. PubMed ID: 12094644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the auditory organ in type 1 diabetes mellitus.
    Dąbrowski M; Mielnik-Niedzielska G; Nowakowski A
    Endokrynol Pol; 2011; 62(2):138-44. PubMed ID: 21528476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions.
    Erdem T; Ozturan O; Miman MC; Ozturk C; Karatas E
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):62-6. PubMed ID: 12582780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is type 1 diabetes mellitus a cause for subtle hearing loss in pediatric patients?
    ALDajani N; ALkurdi A; ALMutair A; ALdraiwesh A; ALMazrou KA
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):1867-71. PubMed ID: 24627078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional hearing deficits in children with Type 1 diabetes.
    Rance G; Chisari D; Edvall N; Cameron F
    Diabet Med; 2016 Sep; 33(9):1268-74. PubMed ID: 26823194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Otoacoustic emissions in diabetic patients with normal hearing].
    Hosch H; Ottaviani F
    Schweiz Med Wochenschr; 2000; Suppl 125():83S-85S. PubMed ID: 11141950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Otoacoustic emission and auditory efferent function testing in normal subjects and patients with sensori-neural hearing loss].
    Liang F; Liu C; Liu B
    Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):763-6. PubMed ID: 9275520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochlear, auditory brainstem responses in Type 1 diabetes: relationship with metabolic variables and diabetic complications.
    Lasagni A; Giordano P; Lacilla M; Raviolo A; Trento M; Camussi E; Grassi G; Charrier L; Cavallo F; Albera R; Porta M; Zanone MM
    Diabet Med; 2016 Sep; 33(9):1260-7. PubMed ID: 26605750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing profile and MRI myelination of auditory pathway in Pelizaeus-Merzbacher disease.
    Kuan CC; Sano M; Kaga K; Kodama M; Kodama K
    Acta Otolaryngol; 2008 May; 128(5):539-46. PubMed ID: 18421608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory Impairment in Young Type 1 Diabetics.
    Hou Y; Xiao X; Ren J; Wang Y; Zhao F
    Arch Med Res; 2015 Oct; 46(7):539-45. PubMed ID: 26385484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronological changes in compromised olivocochlear activity and the effect of insulin in diabetic Wistar rats.
    Wu HP; Guo YL; Cheng TJ; Hsu CJ
    Hear Res; 2010 Dec; 270(1-2):173-8. PubMed ID: 20678565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory brainstem latencies in type I (insulin-dependent) diabetic patients.
    Virtaniemi J; Laakso M; Kärjä J; Nuutinen J; Karjalainen S
    Am J Otolaryngol; 1993; 14(6):413-8. PubMed ID: 8285312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory evaluation in patients with type 1 diabetes.
    Pessin AB; Martins RH; Pimenta Wde P; Simões AC; Marsiglia A; Amaral AV
    Ann Otol Rhinol Laryngol; 2008 May; 117(5):366-70. PubMed ID: 18564534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.